Cantor Fitzgerald analyst Eric Schmidt reiterated an Overweight rating on Tango Therapeutics Inc. (NASDAQ: TNGX).The analyst commented, "Last week, Tango ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE